BOSENTAN CONTROLLED RELEASE ORAL PREPARATION

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20140377346A1
SERIAL NO

14369406

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided are an extended release preparation for oral administration of bosentan including bosentan, a pharmaceutically acceptable salt thereof or a solvate thereof as an active ingredient and a hydrophilic polymer as a sustained release excipient, and a method of manufacturing the same. Accordingly, the number of administrations of the bosentan, a pharmaceutically acceptable salt thereof or a solvate thereof may be reduced, thereby enhancing ease of administration and patient compliance. In addition, the extended release preparation for oral administration of bosentan may be effectively manufactured.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
HANALL BIOPHARMA CO LTD400-1 SANGSEO-DONG DAEDEOK-GU DAEJEON 306-120

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Choi, Seong Choon Seoul, KR 1 0
Kim, Sung Wuk Seongnam-si, KR 51 282
Koo, Ja Seong Deajeon, KR 18 130
Lee, Na Young Daejeon, KR 14 3
Sun, Sang Ouk Daejeon, KR 6 28

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation